NYSE:ATNM

Actinium Pharmaceuticals, Inc Stock Predictions

New York Stock Exchange > Healthcare > Biotechnology

Open Broker Account

$9.80

-0.0500 (-0.508%)

At Close: May 17, 2024

Currently predicting for Mon, 20 May 2024

Trading levels for ATNM

Fibonacci Support & Resistance Levels

		Level	Price
	Resistance	R3	10.21	4.22 %
		R2	10.03	2.35 %
		R1	9.92	1.19 %
Current price:			9.80
	Support	S1	9.55	-2.55 %
		S2	9.44	-3.71 %
		S3	9.25	-5.58 %

Accumulated Volume Support & Resistance Levels

		Level	Price
	Resistance	R3	0	.
		R2	9.89	0.92 %
		R1	9.85	0.510 %
Current price			9.80
	Support	S1	9.20	-6.12%
		S2	9.11	-7.04%
		S3	8.21	-16.22%

ATNM Predictions History

5 years ago
NameNotImportant predicted that ATNM for 2019-04-23 is going $0.285 (-96.90%)

5 years ago
JS predicted that ATNM for 2019-04-02 is going $0.582 (-96.77%)

5 years ago
PumpTheseNumbers predicted that ATNM for 2019-04-02 is going $0.580 (-96.78%)

5 years ago
Ronald.Ventura.105021 predicted that ATNM for 2019-04-02 is going $0.508 (-97.18%)

Rank:

About Actinium Pharmaceuticals, Inc

Actinium Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on developing and commercializing therapies for bone marrow transplant (BMT) or a type of cellular therapy, and for other adoptive cell therapies. Its lead product candidate, I-131 apamistamab (Iomab-B) that is in a pivotal Phase III clinical trial for elderly relapsed or refractory acute myeloid leukemia trial for BMT conditioning; and a Phase I study with a CD19... ATNM Profile

Golden Star

Ticker	Date	Change	Price
LYV	May 15	0.114%	$96.48
RL	May 15	0.539%	$166.98
PAGS	May 15	0.157%	$12.74
EVBG	May 15	0.230%	$34.79
INBX	May 15	0.96%	$34.37
CME	May 14	1.11%	$210.80
VGIT	May 14	0.173%	$57.83
VCLT	May 14	0.726%	$75.73
BNDX	May 14	0.267%	$48.60
FIXD	May 14	0.303%	$42.89

Unlock

Top Fintech Company

featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by

Sign In